Progyny, Inc. (NASDAQ:PGNY) CEO David J. Schlanger sold 112,020 shares of Progyny stock in a transaction that occurred on Tuesday, April 6th. The shares were sold at an average price of $46.10, for a total value of $5,164,122.00.
NASDAQ PGNY opened at $44.87 on Thursday. Progyny, Inc. has a 12 month low of $17.90 and a 12 month high of $53.48. The firm has a market capitalization of $3.91 billion, a PE ratio of 407.91 and a beta of 1.83. The company’s 50 day simple moving average is $46.21 and its 200 day simple moving average is $39.10.
Progyny (NASDAQ:PGNY) last posted its quarterly earnings results on Wednesday, February 24th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.01. The firm had revenue of $100.30 million for the quarter. Progyny had a net margin of 1.03% and a return on equity of 7.43%. Analysts forecast that Progyny, Inc. will post 0.14 EPS for the current year.
PGNY has been the topic of a number of recent analyst reports. Bank of America raised Progyny from a “neutral” rating to a “buy” rating in a report on Tuesday, March 16th. Zacks Investment Research lowered shares of Progyny from a “hold” rating to a “sell” rating in a research note on Saturday, February 27th. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $37.71.
Institutional investors have recently bought and sold shares of the business. GW&K Investment Management LLC grew its position in Progyny by 27.3% in the fourth quarter. GW&K Investment Management LLC now owns 846,802 shares of the company’s stock worth $35,896,000 after buying an additional 181,412 shares during the last quarter. Strs Ohio grew its position in Progyny by 74.2% in the third quarter. Strs Ohio now owns 147,900 shares of the company’s stock worth $4,352,000 after buying an additional 63,000 shares during the last quarter. UBS Asset Management Americas Inc. acquired a new position in Progyny in the third quarter worth approximately $312,000. Weld Capital Management LLC grew its position in Progyny by 87.8% in the third quarter. Weld Capital Management LLC now owns 19,939 shares of the company’s stock worth $587,000 after buying an additional 9,321 shares during the last quarter. Finally, Clearbridge Investments LLC grew its position in Progyny by 0.4% in the fourth quarter. Clearbridge Investments LLC now owns 2,536,357 shares of the company’s stock worth $107,516,000 after buying an additional 10,135 shares during the last quarter. Hedge funds and other institutional investors own 58.54% of the company’s stock.
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More: S&P/TSX Index
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.